Orthopedic Implants Market Size At Around US$ 22 Bn In 2030

The orthopedic implant market would grow at a CAGR of 4.67% over the predicted time frame. The market is expected to increase in value from US$ 50.03 Bn in 2022 to US$ 72.1 Bn in 2030.

The on orthopedic implant Market, which provides a business strategy, research & development activities, concise outline of the market valuation, valuable insights pertaining to market share, size, supply chain analysis, competitive landscape and regional proliferation of this industry.

Download Free Sample@https://www.precedenceresearch.com/sample/1884

Report Scope of the Orthopedic Implants Market 

Report Coverage	Details
Market Size by 2030	USD 72.1 Billion
Growth Rate from 2022 to 2030	CAGR of 4.67%
North America Market Share in 2021	42.5%
Metallic Biomaterials Segment Market Share in 2021	58%
Base Year	2021
Forecast Period	2022 to 2030
Segments Covered	Product, Type, Biomaterial, P

A recent report provides crucial insights along with application based and forecast information in the Global Orthopedic implant Market. The report provides a comprehensive analysis of key factors that are expected to drive the growth of this market. This study also provides a detailed overview of the opportunities along with the current trends observed in the Orthopedic implant market.

A quantitative analysis of the industry is compiled for a period of 10 years in order to assist players to grow in the market. Insights on specific revenue figures generated are also given in the report, along with projected revenue at the end of the forecast period.

Companies and Manufacturers Covered

The study covers key players operating in the market along with prime schemes and strategies implemented by each player to hold high positions in the industry. Such a tough vendor landscape provides a competitive outlook of the industry, consequently existing as a key insight. These insights were thoroughly analysed and prime business strategies and products that offer high revenue generation capacities were identified. Key players of the global Orthopedic implant market are included as given below:

Orthopedic implant Market Key Players

• Zimmer Biomet Holdings
• Stryker Corporation
• Johnson & Johnson 
• Medtronic Plc
• NuVasive
• Arthrex, Inc.
• DJO Finance LLC
• Smith and Nephew Plc.
• CONMED Corporation.

Market Segments

By Product

• Reconstructive Joint Replacements
  • Knee Replacement Implants
  • Hip Replacement Implants
  • Extremities
    • Upper Extremity Reconstruction
      • Elbow
      • Shoulder
      • Hand Wrist
    • Lower Extremity Reconstruction
      • Upper
      • Lower
• Spinal Implants
  • Spinal Fusion Implants
    • Thoracolumbar Devices
    • Cervical Fixation Devices
    • Interbody Fusion Devices
  • Vertebral Compression Fracture (VCF) Devices
    • Balloon Kyphoplasty Devices
    • Vertebroplasty Devices
  • Motion Preservation Devices/Non-Fusion Devices
    • Dynamic Stabilization Devices
    • Artificial Disc Replacement Devices
    • Annulus Repair Devices
    • Nuclear Disc Prostheses
• Dental Implants
  • Root Form Dental Implants
  • Plate Form Dental Implants
• Trauma
• Orthobiologics
  • Demineralized Bone Matrix (DBM)
  • Allograft
  • Bone Morphogenetic Protein (BMP)
  • Viscosupplementation Products
  • Synthetic Bone Substitutes
  • Others
• Others

By Type

• Wrist & Shoulder
• Dental
• Knee
• Hip
• Spine
• Ankle

By Biomaterial

• Metallic Biomaterials
  • Stainless Steel
  • Titanium Alloy
  • Cobalt Alloy
  • Others
• Ceramic Biomaterials
• Polymers Biomaterials
• Others

By Procedure

• Open Surgery
• Minimally Invasive Surgery (MIS)
• Others

By End User

• Hospitals
• Orthopedic Clinics
• Home Cares
• Others

By Geography

• North America
  • U.S.
  • Canada
• Europe
  • U.K.
  • Germany
  • France
• Asia-Pacific
  • China
  • India
  • Japan
  • South Korea
  • Malaysia
  • Philippines
• Latin America
  • Brazil
  • Rest of Latin America
• Middle East & Africa (MEA)
  • GCC
  • North Africa
  • South Africa
  • Rest of the Middle East & Africa

Report Objectives

• To define, describe, and forecast the global orthopedic implant market based on product, and region
• To provide detailed information regarding the major factors influencing the growth of the market (drivers, opportunities, and industry-specific challenges)
• To strategically analyze micromarkets1 with respect to individual growth trends, future prospects, and contributions to the total market
• To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
• To forecast the size of market segments with respect to four main regions—North America, Europe, Asia Pacific and the Rest of the World (RoW)2
• To strategically profile key players and comprehensively analyze their product portfolios, market shares, and core competencies3
• To track and analyze competitive developments such as acquisitions, expansions, new product launches, and partnerships in the orthopedic implant market

Table of Content

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Orthopedic Implants Market 

5.1. COVID-19 Landscape: Orthopedic Implants Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Orthopedic Implants Market, By Product

8.1. Orthopedic Implants Market, by Product, 2022-2030

8.1.1. Reconstructive Joint Replacements

8.1.1.1. Market Revenue and Forecast (2017-2030)

8.1.2. Spinal Implants

8.1.2.1. Market Revenue and Forecast (2017-2030)

8.1.3. Dental Implants

8.1.3.1. Market Revenue and Forecast (2017-2030)

8.1.4. Trauma

8.1.4.1. Market Revenue and Forecast (2017-2030)

8.1.5. Orthobiologics

8.1.5.1. Market Revenue and Forecast (2017-2030)

8.1.6. Others

8.1.6.1. Market Revenue and Forecast (2017-2030)

Chapter 9. Global Orthopedic Implants Market, By Type

9.1. Orthopedic Implants Market, by Type, 2022-2030

9.1.1. Wrist & Shoulder

9.1.1.1. Market Revenue and Forecast (2017-2030)

9.1.2. Dental

9.1.2.1. Market Revenue and Forecast (2017-2030)

9.1.3. Knee

9.1.3.1. Market Revenue and Forecast (2017-2030)

9.1.4. Hip

9.1.4.1. Market Revenue and Forecast (2017-2030)

9.1.5. Spine

9.1.5.1. Market Revenue and Forecast (2017-2030)

9.1.6. Ankle

9.1.6.1. Market Revenue and Forecast (2017-2030)

Chapter 10. Global Orthopedic Implants Market, By Biomaterial 

10.1. Orthopedic Implants Market, by Biomaterial, 2022-2030

10.1.1. Metallic Biomaterials

10.1.1.1. Market Revenue and Forecast (2017-2030)

10.1.2. Ceramic Biomaterials

10.1.2.1. Market Revenue and Forecast (2017-2030)

10.1.3. Polymers Biomaterials

10.1.3.1. Market Revenue and Forecast (2017-2030)

10.1.4. Others

10.1.4.1. Market Revenue and Forecast (2017-2030)

Chapter 11. Global Orthopedic Implants Market, By Procedure

11.1. Orthopedic Implants Market, by Procedure, 2022-2030

11.1.1. Open Surgery

11.1.1.1. Market Revenue and Forecast (2017-2030)

11.1.2. Minimally Invasive Surgery (MIS)

11.1.2.1. Market Revenue and Forecast (2017-2030)

11.1.3. Others

11.1.3.1. Market Revenue and Forecast (2017-2030)

Chapter 12. Global Orthopedic Implants Market, By End User

12.1. Orthopedic Implants Market, by End User, 2022-2030

12.1.1. Hospitals

12.1.1.1. Market Revenue and Forecast (2017-2030)

12.1.2. Orthopedic Clinics

12.1.2.1. Market Revenue and Forecast (2017-2030)

12.1.3. Home Cares

12.1.3.1. Market Revenue and Forecast (2017-2030)

12.1.4. Others

12.1.4.1. Market Revenue and Forecast (2017-2030)

Chapter 13. Global Orthopedic Implants Market, Regional Estimates and Trend Forecast

13.1. North America

13.1.1. Market Revenue and Forecast, by Product (2017-2030)

13.1.2. Market Revenue and Forecast, by Type (2017-2030)

13.1.3. Market Revenue and Forecast, by Biomaterial (2017-2030)

13.1.4. Market Revenue and Forecast, by Procedure (2017-2030)

13.1.5. Market Revenue and Forecast, by End User (2017-2030)

13.1.6. U.S.

13.1.6.1. Market Revenue and Forecast, by Product (2017-2030)

13.1.6.2. Market Revenue and Forecast, by Type (2017-2030)

13.1.6.3. Market Revenue and Forecast, by Biomaterial (2017-2030)

13.1.6.4. Market Revenue and Forecast, by Procedure (2017-2030)

13.1.7. Market Revenue and Forecast, by End User (2017-2030) 

13.1.8. Rest of North America

13.1.8.1. Market Revenue and Forecast, by Product (2017-2030)

13.1.8.2. Market Revenue and Forecast, by Type (2017-2030)

13.1.8.3. Market Revenue and Forecast, by Biomaterial (2017-2030)

13.1.8.4. Market Revenue and Forecast, by Procedure (2017-2030)

13.1.8.5. Market Revenue and Forecast, by End User (2017-2030)

13.2. Europe

13.2.1. Market Revenue and Forecast, by Product (2017-2030)

13.2.2. Market Revenue and Forecast, by Type (2017-2030)

13.2.3. Market Revenue and Forecast, by Biomaterial (2017-2030)

13.2.4. Market Revenue and Forecast, by Procedure (2017-2030) 

13.2.5. Market Revenue and Forecast, by End User (2017-2030) 

13.2.6. UK

13.2.6.1. Market Revenue and Forecast, by Product (2017-2030)

13.2.6.2. Market Revenue and Forecast, by Type (2017-2030)

13.2.6.3. Market Revenue and Forecast, by Biomaterial (2017-2030)

13.2.7. Market Revenue and Forecast, by Procedure (2017-2030) 

13.2.8. Market Revenue and Forecast, by End User (2017-2030) 

13.2.9. Germany

13.2.9.1. Market Revenue and Forecast, by Product (2017-2030)

13.2.9.2. Market Revenue and Forecast, by Type (2017-2030)

13.2.9.3. Market Revenue and Forecast, by Biomaterial (2017-2030)

13.2.10. Market Revenue and Forecast, by Procedure (2017-2030)

13.2.11. Market Revenue and Forecast, by End User (2017-2030)

13.2.12. France

13.2.12.1. Market Revenue and Forecast, by Product (2017-2030)

13.2.12.2. Market Revenue and Forecast, by Type (2017-2030)

13.2.12.3. Market Revenue and Forecast, by Biomaterial (2017-2030)

13.2.12.4. Market Revenue and Forecast, by Procedure (2017-2030)

13.2.13. Market Revenue and Forecast, by End User (2017-2030)

13.2.14. Rest of Europe

13.2.14.1. Market Revenue and Forecast, by Product (2017-2030)

13.2.14.2. Market Revenue and Forecast, by Type (2017-2030)

13.2.14.3. Market Revenue and Forecast, by Biomaterial (2017-2030)

13.2.14.4. Market Revenue and Forecast, by Procedure (2017-2030)

13.2.15. Market Revenue and Forecast, by End User (2017-2030)

13.3. APAC

13.3.1. Market Revenue and Forecast, by Product (2017-2030)

13.3.2. Market Revenue and Forecast, by Type (2017-2030)

13.3.3. Market Revenue and Forecast, by Biomaterial (2017-2030)

13.3.4. Market Revenue and Forecast, by Procedure (2017-2030)

13.3.5. Market Revenue and Forecast, by End User (2017-2030)

13.3.6. India

13.3.6.1. Market Revenue and Forecast, by Product (2017-2030)

13.3.6.2. Market Revenue and Forecast, by Type (2017-2030)

13.3.6.3. Market Revenue and Forecast, by Biomaterial (2017-2030)

13.3.6.4. Market Revenue and Forecast, by Procedure (2017-2030)

13.3.7. Market Revenue and Forecast, by End User (2017-2030)

13.3.8. China

13.3.8.1. Market Revenue and Forecast, by Product (2017-2030)

13.3.8.2. Market Revenue and Forecast, by Type (2017-2030)

13.3.8.3. Market Revenue and Forecast, by Biomaterial (2017-2030)

13.3.8.4. Market Revenue and Forecast, by Procedure (2017-2030)

13.3.9. Market Revenue and Forecast, by End User (2017-2030)

13.3.10. Japan

13.3.10.1. Market Revenue and Forecast, by Product (2017-2030)

13.3.10.2. Market Revenue and Forecast, by Type (2017-2030)

13.3.10.3. Market Revenue and Forecast, by Biomaterial (2017-2030)

13.3.10.4. Market Revenue and Forecast, by Procedure (2017-2030)

13.3.10.5. Market Revenue and Forecast, by End User (2017-2030)

13.3.11. Rest of APAC

13.3.11.1. Market Revenue and Forecast, by Product (2017-2030)

13.3.11.2. Market Revenue and Forecast, by Type (2017-2030)

13.3.11.3. Market Revenue and Forecast, by Biomaterial (2017-2030)

13.3.11.4. Market Revenue and Forecast, by Procedure (2017-2030)

13.3.11.5. Market Revenue and Forecast, by End User (2017-2030)

13.4. MEA

13.4.1. Market Revenue and Forecast, by Product (2017-2030)

13.4.2. Market Revenue and Forecast, by Type (2017-2030)

13.4.3. Market Revenue and Forecast, by Biomaterial (2017-2030)

13.4.4. Market Revenue and Forecast, by Procedure (2017-2030)

13.4.5. Market Revenue and Forecast, by End User (2017-2030)

13.4.6. GCC

13.4.6.1. Market Revenue and Forecast, by Product (2017-2030)

13.4.6.2. Market Revenue and Forecast, by Type (2017-2030)

13.4.6.3. Market Revenue and Forecast, by Biomaterial (2017-2030)

13.4.6.4. Market Revenue and Forecast, by Procedure (2017-2030)

13.4.7. Market Revenue and Forecast, by End User (2017-2030)

13.4.8. North Africa

13.4.8.1. Market Revenue and Forecast, by Product (2017-2030)

13.4.8.2. Market Revenue and Forecast, by Type (2017-2030)

13.4.8.3. Market Revenue and Forecast, by Biomaterial (2017-2030)

13.4.8.4. Market Revenue and Forecast, by Procedure (2017-2030)

13.4.9. Market Revenue and Forecast, by End User (2017-2030)

13.4.10. South Africa

13.4.10.1. Market Revenue and Forecast, by Product (2017-2030)

13.4.10.2. Market Revenue and Forecast, by Type (2017-2030)

13.4.10.3. Market Revenue and Forecast, by Biomaterial (2017-2030)

13.4.10.4. Market Revenue and Forecast, by Procedure (2017-2030)

13.4.10.5. Market Revenue and Forecast, by End User (2017-2030)

13.4.11. Rest of MEA

13.4.11.1. Market Revenue and Forecast, by Product (2017-2030)

13.4.11.2. Market Revenue and Forecast, by Type (2017-2030)

13.4.11.3. Market Revenue and Forecast, by Biomaterial (2017-2030)

13.4.11.4. Market Revenue and Forecast, by Procedure (2017-2030)

13.4.11.5. Market Revenue and Forecast, by End User (2017-2030)

13.5. Latin America

13.5.1. Market Revenue and Forecast, by Product (2017-2030)

13.5.2. Market Revenue and Forecast, by Type (2017-2030)

13.5.3. Market Revenue and Forecast, by Biomaterial (2017-2030)

13.5.4. Market Revenue and Forecast, by Procedure (2017-2030)

13.5.5. Market Revenue and Forecast, by End User (2017-2030)

13.5.6. Brazil

13.5.6.1. Market Revenue and Forecast, by Product (2017-2030)

13.5.6.2. Market Revenue and Forecast, by Type (2017-2030)

13.5.6.3. Market Revenue and Forecast, by Biomaterial (2017-2030)

13.5.6.4. Market Revenue and Forecast, by Procedure (2017-2030)

13.5.7. Market Revenue and Forecast, by End User (2017-2030)

13.5.8. Rest of LATAM

13.5.8.1. Market Revenue and Forecast, by Product (2017-2030)

13.5.8.2. Market Revenue and Forecast, by Type (2017-2030)

13.5.8.3. Market Revenue and Forecast, by Biomaterial (2017-2030)

13.5.8.4. Market Revenue and Forecast, by Procedure (2017-2030)

13.5.8.5. Market Revenue and Forecast, by End User (2017-2030)

Chapter 14. Company Profiles

14.1. Zimmer Biomet Holdings

14.1.1. Company Overview

14.1.2. Product Offerings

14.1.3. Financial Performance

14.1.4. Recent Initiatives

14.2. Stryker Corporation

14.2.1. Company Overview

14.2.2. Product Offerings

14.2.3. Financial Performance

14.2.4. Recent Initiatives

14.3. Johnson & Johnson

14.3.1. Company Overview

14.3.2. Product Offerings

14.3.3. Financial Performance

14.3.4. Recent Initiatives

14.4. Medtronic Plc

14.4.1. Company Overview

14.4.2. Product Offerings

14.4.3. Financial Performance

14.4.4. Recent Initiatives

14.5. NuVasive

14.5.1. Company Overview

14.5.2. Product Offerings

14.5.3. Financial Performance

14.5.4. Recent Initiatives

14.6. Arthrex, Inc.

14.6.1. Company Overview

14.6.2. Product Offerings

14.6.3. Financial Performance

14.6.4. Recent Initiatives

14.7. DJO Finance LLC

14.7.1. Company Overview

14.7.2. Product Offerings

14.7.3. Financial Performance

14.7.4. Recent Initiatives

14.8. Smith and Nephew Plc.

14.8.1. Company Overview

14.8.2. Product Offerings

14.8.3. Financial Performance

14.8.4. Recent Initiatives

14.9. CONMED Corporation

14.9.1. Company Overview

14.9.2. Product Offerings

14.9.3. Financial Performance

14.9.4. Recent Initiatives

Chapter 15. Research Methodology

15.1. Primary Research

15.2. Secondary Research

15.3. Assumptions

Chapter 16. Appendix

16.1. About Us

16.2. Glossary of Terms

Contact Us:

Precedence Research

Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada

Call: +1 774 402 6168

Email: sales@precedenceresearch.com

Website: https://www.precedenceresearch.com

 Blog: https://www.pharma-geek.com